Citadel Advisors’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,359
| Closed | -$3.1K | – | 6759 |
|
|
2023
Q2 | $3.1K | Buy |
+3,359
| New | +$3.1K | ﹤0.01% | 5511 |
|
|
2023
Q1 | – | Sell |
-847
| Closed | -$2.13K | – | 6832 |
|
|
2022
Q4 | $2.13K | Sell |
847
-51,278
| -98% | -$129K | ﹤0.01% | 5881 |
|
|
2022
Q3 | $72K | Buy |
52,125
+29,551
| +131% | +$40.8K | ﹤0.01% | 5204 |
|
|
2022
Q2 | $28K | Buy |
+22,574
| New | +$28K | ﹤0.01% | 5654 |
|
|
2021
Q4 | – | Sell |
-36,681
| Closed | -$94K | – | 7448 |
|
|
2021
Q3 | $94K | Buy |
+36,681
| New | +$94K | ﹤0.01% | 5911 |
|
|
2021
Q2 | – | Sell |
-61,308
| Closed | -$191K | – | 7307 |
|
|
2021
Q1 | $191K | Buy |
61,308
+44,797
| +271% | +$140K | ﹤0.01% | 5448 |
|
|
2020
Q4 | $43K | Buy |
+16,511
| New | +$43K | ﹤0.01% | 4885 |
|
|
2019
Q3 | – | Sell |
-17,078
| Closed | -$67K | – | 5257 |
|
|
2019
Q2 | $67K | Buy |
+17,078
| New | +$67K | ﹤0.01% | 4318 |
|
|
2015
Q3 | – | Sell |
-1,847
| Closed | -$68K | – | 4370 |
|
|
2015
Q2 | $68K | Buy |
1,847
+1,408
| +321% | +$51.8K | ﹤0.01% | 3371 |
|
|
2015
Q1 | $20K | Sell |
439
-389
| -47% | -$17.7K | ﹤0.01% | 3543 |
|
|
2014
Q4 | $50K | Buy |
828
+614
| +287% | +$37.1K | ﹤0.01% | 3399 |
|
|
2014
Q3 | $18K | Buy |
+214
| New | +$18K | ﹤0.01% | 3355 |
|
|
2013
Q4 | – | Sell |
-128
| Closed | -$23K | – | 3242 |
|
|
2013
Q3 | $23K | Buy |
+128
| New | +$23K | ﹤0.01% | 2716 |
|